Skip to content

000513.SZ

Livzon Pharmaceutical Group, Inc.

SZSE · Healthcare · C 制造业 · CN

CNY 26.34
−9.98%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue10.7B12.0B11.8B12.4B12.6B
Cost of Revenue3.9B4.1B4.1B4.5B4.5B
Gross Profit6.8B7.9B7.7B8.0B8.2B
Operating Expenses
R&D Expense839.5M937.9M1.0B1.3B1.4B
SG&A Expense147.5M
General & Admin Expense366.4M598.5M613.1M654.3M656.9M
Selling & Marketing Expense2.8B3.6B3.3B3.6B3.9B
Other Expenses382.7M
Total Operating Expenses4.4B5.1B4.9B5.5B5.8B
Cost and Expenses8.3B9.2B9.0B9.9B10.3B
Operating Income (EBIT)2.4B2.9B2.8B2.4B2.4B
Non-Operating
Interest Income41.5M
Interest Expense12.1M
Net Interest Income29.4M
Other Non-Op Income/Expense(3.9M)
Non-Operating Income (excl Interest)84.1M
EBT (Pre-Tax Income)2.4B2.9B2.8B2.4B2.3B
Income Tax Expense378.9M451.0M501.7M485.1M375.0M
Bottom Line
Net Income1.7B2.0B2.1B2.0B1.9B
Earnings from Cont. Ops2.0B2.4B2.3B1.9B2.0B
Earnings from Discont. Ops
Bottom Line Net Income1.7B2.0B2.1B2.0B1.9B
Per Share
Basic EPSCN¥1.89CN¥2.27CN¥2.24CN¥2.10CN¥2.04
Diluted EPSCN¥1.89CN¥2.27CN¥2.24CN¥2.10CN¥2.04
Revenue Per ShareCN¥12.09CN¥13.49CN¥12.84CN¥13.36CN¥13.49
Shares
Basic Shares Outstanding887.9M891.3M920.1M930.3M936.0M
Diluted Shares Outstanding887.9M891.3M920.1M930.3M936.0M
Profitability Metrics
EBITDA549.9M3.5B3.5B3.3B3.0B
D&A158.2M603.8M608.0M866.4M663.9M
EBIT394.2M

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026